Kintayl Capital sells $8.64M in Core Scientific shares, cutting stake amid company’s shift to colocation services.

Kintayl Capital sold 495,390 shares of Core Scientific in Q4 2025, worth about $8.64 million, reducing its stake from 6.3% to 0.66% of its assets under management. The sale reflects a strategic move as Core Scientific transitions from self-mining to more stable colocation hosting services, despite revenue declines and ongoing heavy infrastructure investments. The company’s stock has risen 84% in the past year, outperforming the S&P 500, but adjusted EBITDA remains negative as it shifts focus to long-term contracts and power capacity for AI and enterprise clients. Investors should note the importance of balancing gains with disciplined position sizing during this transition.